dc.contributor.author |
Borneman, JP |
|
dc.date.accessioned |
2019-04-12T11:14:18Z |
|
dc.date.available |
2019-04-12T11:14:18Z |
|
dc.date.issued |
2007 |
|
dc.identifier.citation |
American Journal of Homeopathic Medicine, Vol.100(4) |
en_US |
dc.identifier.uri |
http://aohindia.in:8080/xmlui/handle/123456789/1982 |
|
dc.description.abstract |
FDA classifications and regulation of allopathic drugs homeopathic drugs and dietary supplements are contrasted. The role of the HPCUS in regulation of homeopathic medicines is described and the HPCUS durg approval process is detailed. |
en_US |
dc.language.iso |
en |
en_US |
dc.subject |
Allopathic drug |
en_US |
dc.subject |
FDA classification and regulation |
en_US |
dc.title |
The regulation of homeopathic drugs as complementary and alternative medicine products: The role of the homeopathic pharmacopoeia of the United States |
en_US |
dc.type |
Article |
en_US |